In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>

<i>Acinetobacter baumannii</i> is currently classified as one of six pathogens that contribute to increased patient mortality. Thus, exploratory studies navigating alternative treatment strategies are of supreme interest. Herein, we completed minimum inhibitory concentration (MIC) testing, and time-...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Jacinda C. Abdul-Mutakabbir, Juwon Yim, Logan Nguyen, Philip T. Maassen, Kyle Stamper, Zain Shiekh, Razieh Kebriaei, Ryan K. Shields, Mariana Castanheira, Keith S. Kaye, Michael J. Rybak
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2021-07-01
סדרה:	Antibiotics
נושאים:	<i>Acinetobacter baumannii</i> multidrug-resistant carbapenem-resistant colistin-resistant
גישה מקוונת:	https://www.mdpi.com/2079-6382/10/7/880
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!